Targeted depletion of PD-1-expressing cells induces immune tolerance through peripheral clonal deletion

Sci Immunol. 2024 Apr 26;9(94):eadh0085. doi: 10.1126/sciimmunol.adh0085. Epub 2024 Apr 26.

Abstract

Thymic negative selection of the T cell receptor (TCR) repertoire is essential for establishing self-tolerance and acquired allograft tolerance following organ transplantation. However, it is unclear whether and how peripheral clonal deletion of alloreactive T cells induces transplantation tolerance. Here, we establish that programmed cell death protein 1 (PD-1) is a hallmark of alloreactive T cells and is associated with clonal expansion after alloantigen encounter. Moreover, we found that diphtheria toxin receptor (DTR)-mediated ablation of PD-1+ cells reshaped the TCR repertoire through peripheral clonal deletion of alloreactive T cells and promoted tolerance in mouse transplantation models. In addition, by using PD-1-specific depleting antibodies, we found that antibody-mediated depletion of PD-1+ cells prevented heart transplant rejection and the development of experimental autoimmune encephalomyelitis (EAE) in humanized PD-1 mice. Thus, these data suggest that PD-1 is an attractive target for peripheral clonal deletion and induction of immune tolerance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Clonal Deletion* / immunology
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Female
  • Heart Transplantation
  • Humans
  • Immune Tolerance* / immunology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL*
  • Mice, Knockout
  • Programmed Cell Death 1 Receptor* / immunology
  • T-Lymphocytes / immunology

Substances

  • Programmed Cell Death 1 Receptor
  • Pdcd1 protein, mouse